chr1-156299042-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001004319.3(VHLL):āc.148T>Cā(p.Ser50Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000434 in 1,613,242 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S50L) has been classified as Uncertain significance.
Frequency
Consequence
NM_001004319.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VHLL | NM_001004319.3 | c.148T>C | p.Ser50Pro | missense_variant | 1/1 | ENST00000339922.5 | NP_001004319.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VHLL | ENST00000339922.5 | c.148T>C | p.Ser50Pro | missense_variant | 1/1 | 6 | NM_001004319.3 | ENSP00000464258.2 |
Frequencies
GnomAD3 genomes AF: 0.000178 AC: 27AN: 152106Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000519 AC: 13AN: 250616Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135578
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1461018Hom.: 0 Cov.: 30 AF XY: 0.0000303 AC XY: 22AN XY: 726878
GnomAD4 genome AF: 0.000191 AC: 29AN: 152224Hom.: 0 Cov.: 30 AF XY: 0.000188 AC XY: 14AN XY: 74436
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2021 | The c.148T>C (p.S50P) alteration is located in exon 1 (coding exon 1) of the VHLL gene. This alteration results from a T to C substitution at nucleotide position 148, causing the serine (S) at amino acid position 50 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at